SCREENER COMPARE ANY 2 STOCKS

EXCHANGE TRADED FUND

BIB

ProShares Ultra Nasdaq Biotechnology

$122.16 ▲ 2.73%

+$3.25 TODAY

FUND FACTS

Manager ProShares

Assets $103.78M

Expense ratio 1.19%

Inception Apr 7, 2010

Asset class Equity

Holdings 248

Volume 14.47K

Avg volume 11.27K

ABOUT THIS FUND

ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.

PRICE

$122.16 ▲ UP 2.73% (+$3.25)

HOLDINGS

TOP 20 OF 248 · 30.02% OF THE FUND

RANK STOCK WEIGHT SHARES VALUE

01

AMGN Amgen Inc. 4.50% 10.63K $4.67M

02

VRTX Vertex Pharmaceuticals Incorporated 4.23% 8.01K $4.39M

03

GILD Gilead Sciences, Inc. 3.75% 26.65K $3.89M

04

REGN Regeneron Pharmaceuticals, Inc. 2.83% 3.52K $2.93M

05

MRNA Moderna, Inc. 1.90% 13.56K $1.97M

06

RVMD Revolution Medicines, Inc. 1.47% 7.26K $1.52M

07

ILMN Illumina, Inc. 1.09% 5.17K $1.13M

08

BIIB Biogen Inc. 1.05% 5.04K $1.09M

09

ALNY Alnylam Pharmaceuticals, Inc. 1.04% 4.56K $1.08M

10

ARGX argenx SE 0.95% 944 $981.55K

11

INSM Insmed Incorporated 0.90% 7.41K $931.58K

12

RPRX Royalty Pharma plc 0.90% 15.15K $928.97K

13

ROIV Roivant Sciences Ltd. 0.86% 24.57K $892.07K

14

INCY Incyte Corporation 0.84% 6.83K $872.56K

15

GH Guardant Health, Inc. 0.75% 4.53K $773.57K

16

UTHR United Therapeutics Corporation 0.72% 1.45K $744.54K

17

VTRS Viatris Inc. 0.63% 39.79K $649.37K

18

MEDP Medpace Holdings, Inc. 0.58% 974 $604.61K

19

BBIO BridgeBio Pharma, Inc. 0.53% 6.69K $545.24K

20

JAZZ Jazz Pharmaceuticals plc 0.53% 2.14K $545.18K

SECTOR HOLDINGS

TECHNOLOGY IS 51.79% OF THE FUND

Healthcare 51.79%

Cash & Others 43.39%

Financial Services 4.82%

BY REGION

UNITED STATES IS 50.65% OF THE FUND

United States 50.65%

— Other 43.28%

Netherlands 1.24%

United Kingdom 1.20%

Ireland 0.87%

Switzerland 0.61%

Denmark 0.60%

France 0.57%

Germany 0.45%

Canada 0.38%

Luxembourg 0.05%

Spain 0.03%

Australia 0.03%

China 0.03%

Israel 0.02%

Belgium 0.01%

Taiwan 0.01%